SCHEMBL21880293

SCHEMBL21880293

CSc1ccc2nc(C#N)ccc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.60
PPARG P37231 1/20 0.41
NCOA2 Q15596 1/20 0.41
NCOA1 Q15788 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
HPGDS O60760 1/20 0.37
TYMS P04818 1/20 0.36
CYP1A2 P05177 2/20 0.36
TTR P02766 2/20 0.36
SOS2 Q07890 1/20 0.35
KDM4E B2RXH2 3/20 0.34
LMNA P02545 2/20 0.34
POLB P06746 1/20 0.34
CASP6 P55212 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8002770 0.78 NQO1 (0.64) NQO1NPSR1RXFP1L3MBTL1HPGDS
SCHEMBL28491104 0.75 NQO1 (0.60) NQO1HPGDSTTR
SCHEMBL906879 0.75 NQO1 (1.00) NQO1PPARGNCOA2NCOA1NPSR1
SCHEMBL4540271 0.75 CYP1A2 (0.63) TYMSCYP1A2KDM4ELMNAPOLB
SCHEMBL14820395 0.75 HPGDS (0.59) NQO1HPGDSKDM4E
SCHEMBL743391 0.74 NQO1 (0.59) NQO1HPGDSSOS2KDM4EHRH3
SCHEMBL5020158 0.74 NQO1 (0.59) NQO1HPGDSCYP1A2TTRSOS2
SCHEMBL12599791 0.74 NQO1 (0.59) NQO1PPARGNCOA2NCOA1NPSR1
SCHEMBL138949 0.74 NQO1 (0.59) NQO1CYP1A2TTRSOS2KDM4E
SCHEMBL906662 0.74 NQO1 (0.59) NQO1TTRSOS2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200085980-A1 CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2020-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200085980-A1 CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF CASP3, CASP14, CASP6 NQO1 3529/4885PPARG 4807/4885NCOA2 3891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.